Patients with International Prostate Symptom Score @ , total prostatic volume ( TPV ) > @ mL , and maximum flow rate ( Qmax ) < @ mL/s were randomly assigned to the @-reductase inhibitor ( @ARI ) discontinue ( DC-@ARI ) or - blocker discontinue ( DC -- blocker ) group .